Everything You Need to Know about Viva Biotech 2023 Interim Results

News

}

Home / News / Company News / Company News detail

Time: 2023-08-29

Source: Viva Biotech

[Abstract]:Viva Biotech continues to increase the cross-promotion between biology and chemistry businesses and strengthen the construction of a one-stop drug R&D and manufacturing service platform.

Previous Page：Viva Biotech Secures Approximately US$ 210 Million Funding Next Page：Viva Biotech (1873.HK) Announces 2023 Interim Results：Solid Growth in Main Business, Significant Rebound in Profitability

Back

Media contact: vivapr@vivabiotech.com